Literature DB >> 18238819

Cardiac involvement in muscular dystrophies.

R P Beynon1, S G Ray.   

Abstract

The muscular dystrophies are a heterogeneous group of conditions with a variable distribution and prognosis. Cardiac complications are common and may significantly alter both quality and quantity of life. Whilst complications are disease specific, many patients will require long-term cardiology follow-up looking for the development of a cardiomyopathic process or conduction problems. Improvements in diagnostic techniques now allow mutation-specific diagnosis to be made in some patients so adequate counselling, management and screening can be put in place for individuals and their families.

Entities:  

Mesh:

Year:  2008        PMID: 18238819     DOI: 10.1093/qjmed/hcm124

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  7 in total

Review 1.  Progress in gene therapy of dystrophic heart disease.

Authors:  Y Lai; D Duan
Journal:  Gene Ther       Date:  2012-02-09       Impact factor: 5.250

Review 2.  Pharmacology and toxicology of eteplirsen and SRP-5051 for DMD exon 51 skipping: an update.

Authors:  Omar Sheikh; Toshifumi Yokota
Journal:  Arch Toxicol       Date:  2021-11-19       Impact factor: 5.153

3.  Voltage-gated ion channel dysfunction precedes cardiomyopathy development in the dystrophic heart.

Authors:  Xaver Koenig; Sandra Dysek; Stefanie Kimbacher; Agnes K Mike; Rene Cervenka; Peter Lukacs; Katrin Nagl; Xuan B Dang; Hannes Todt; Reginald E Bittner; Karlheinz Hilber
Journal:  PLoS One       Date:  2011-05-23       Impact factor: 3.240

4.  NADPH oxidase-2 inhibition restores contractility and intracellular calcium handling and reduces arrhythmogenicity in dystrophic cardiomyopathy.

Authors:  Daniel R Gonzalez; Adriana V Treuer; Guillaume Lamirault; Vera Mayo; Yenong Cao; Raul A Dulce; Joshua M Hare
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-07-11       Impact factor: 4.733

Review 5.  The Added Value of Cardiac Magnetic Resonance in Muscular Dystrophies.

Authors:  Mariana M Lamacie; Jodi Warman-Chardon; Andrew M Crean; Anca Florian; Karim Wahbi
Journal:  J Neuromuscul Dis       Date:  2019

6.  An Overview of Cardiac Management in Neuromuscular Disease.

Authors:  Renee M Hickey; John D Cullen; George M Sachs
Journal:  Open Cardiovasc Med J       Date:  2016-05-27

Review 7.  Voltage-Dependent Sarcolemmal Ion Channel Abnormalities in the Dystrophin-Deficient Heart.

Authors:  Xaver Koenig; Janine Ebner; Karlheinz Hilber
Journal:  Int J Mol Sci       Date:  2018-10-23       Impact factor: 6.208

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.